Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Single-Arm Exploratory Study of NatureU Histra Disslove on Chronic Urticaria Symptoms
Sponsor: OmniSolutions Laboratory Holdings Limited
Summary
This was a single-center, open-label, single-arm, exploratory self-controlled study evaluating NatureU Histra Disslove in adults with chronic urticaria symptoms. Twenty-four participants were screened, 19 participants were enrolled, and 19 participants completed the study and were included in the effectiveness analysis. Participants took one tablet of the study product orally once daily, 20 minutes before a main meal, for 28 consecutive days. Urticaria Control Test, Urticaria Activity Score 7, and Dermatology Life Quality Index assessments were performed at baseline, Day 14, and Day 28. Safety was monitored during the study.
Official title: A Single-Center, Open-Label, Single-Arm Exploratory Self-Controlled Study of NatureU Histra Disslove on Urticaria Control, Urticaria Activity, and Dermatology Quality of Life in Adults With Chronic Urticaria Symptoms
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
19
Start Date
2024-10-04
Completion Date
2024-11-01
Last Updated
2026-05-28
Healthy Volunteers
No
Conditions
Interventions
NatureU Histra Disslove
NatureU Histra Disslove is a food product containing active diamine oxidase (DAO). Participants took one tablet orally once daily, 20 minutes before a main meal, preferably dinner, for 28 consecutive days.
Locations (1)
Dao County People's Hospital
Yongzhou, Hunan, China